The rise of hemodialysis machines: New technologies in minimizing cardiovascular complications

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 2, 2011, Pages 155-164

  Tetta, Ciro ^a,b   Roy, Thomas ^a   Gatti, Emanule ^a,c   Cerutti, Sergio ^d  

^a Research and Development Department   (Germany)

^b UNIVERSITY OF TURIN   (Italy)

^c DANUBE UNIVERSITY KREMS   (Austria)

^d POLITECNICO DI MILANO   (Italy)

Author keywords

hemodiafiltration; hemodialysis; hemodialysis technology

Indexed keywords

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; ELECTROCARDIOGRAM; EXTRACORPOREAL CIRCULATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE VARIABILITY; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOFILTRATION; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; PERIPHERAL VASCULAR DISEASE; ULTRAFILTRATION; ULTRAVIOLET SPECTROPHOTOMETRY;

AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASES; DIALYSIS SOLUTIONS; ELECTROLYTES; HEART RATE; HEMODYNAMICS; HUMANS; HYPOTENSION; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 79952141356     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.194     Document Type: Article

References (76)

1. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296-1305 (2004).
2. Culleton BF, Larson MG, Wilson PW et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 56, 2214-2219 (1999). (Pubitemid 30004750)
3. Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States; the Dialysis Outcomes and Practice Patterns Study (DOPPS). J. Am. Soc. Nephrol. 14, 3270-3277 (2003). (Pubitemid 37509303)
4. Foley RN. Cardiac disease in chronic uremia: can it explain the reverse epidemiology of hypertension and survival in dialysis patients? Semin. Dial. 17, 275-278 (2004) (Pubitemid 39107649)
5. Barret BJ. Reducing the burden of cardiovascular disease in patients on dialysis. Dial. Transplant. 31, 155-163 (2002).
6. Honda H, Qureshi AR, Heimburger O et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am. J. Kidney Dis. 47(1), 139-148 (2006). (Pubitemid 41828276)
7. Panichi V, Rizza GM, Paoletti S, Bigazzi R et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol. Dial. Transplant. 23(7), 2337-2343 (2008). (Pubitemid 351957592)
8. Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am. J. Kidney Dis. 38, S11-S17 (2001). (Pubitemid 32976704)
9. Ozkahya M, Ok E, Toz H et al. Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol. Dial. Transplant. 21(12), 3506-3513 (2006). (Pubitemid 44817101)
10. Weinreich T, De los Ríos T, Gauly A, Passlick-Deetjen J. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients. Clin. Nephrol. 66(6), 433-439 (2006). (Pubitemid 44896152)
11. Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 298(11), 1291-1299 (2007). (Pubitemid 47443343)
12. Moissl U, Wabel P, Chamney P et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol. Meas. 27, 921-933 (2006). (Pubitemid 44131442)
13. Chamney PW, Kr'mer M, Rode C, Wizemann V. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int. 61, 2250-2258 (2002). (Pubitemid 34539343)
14. Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol. Dial. Transplant. 24(5), 1574-1579 (2009).
15. Maggiore Q, Pizzarelli F, Zoccali C et al. Effect of extracorporeal blood cooling on dialytic arterial hypotension. Proc. Eur. Dial. Transplant. Assoc. 18, 597-602 (1981).
16. Barth C, Boer W, Garzoni D et al. Characteristics of hypotensionprone haemodialysis patients: is there a critical relative blood volume? Nephrol. Dial. Transplant. 18, 1353-1360 (2003). (Pubitemid 36826957)
17. Andrulli S, Colzani S, Mascia F et al. The role of blood volume reduction in the genesis of intradialytic hypotension. Am. J. Kidney Dis. 40, 1244-1254 (2002). (Pubitemid 35403137)
18. Johner C, Chamney PW, Schneditz D, Kraemer M. Evaluation of an ultrasonic blood volume monitor. Nephrol. Dial. Transplant. 13, 2098-2103 (1998). (Pubitemid 28356784)
19. Garzoni D, Keusch G, Kleinoeder T et al. Reduced complications during hemodialysis by automatic blood volume controlled ultrafiltration. Int. J. Artif. Organs 30, 16-24 (2007). (Pubitemid 46566569)
20. Barth C, Boer W, Garzoni D et al. Characteristics of hypotensionprone haemodialysis patients: is there a critical relative blood volume? Nephrol. Dial. Transplant. 18, 1353-1360 (2003). (Pubitemid 36826957)
21. Reddan DN, Szczech LA, Hasselblad V et al. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J. Am. Soc. Nephrol. 16(7), 2162-2169 (2005). (Pubitemid 41716449)
22. Gabrielli D, Kristal B, Katzarski K et al. Improved intradialytic stability during haemodialysis. with blood volume-controlled ultrafiltration. J. Nephrol. 22, 232-240 (2009).
23. Stewart WK, Fleming LW, Manuel MA. Benefits obtained by the use of high sodium dialysate during maintenance haemodialysis. Proc. Eur. Dial. Transplant. Assoc. 9, 111-118 (1972).
24. Port FK, Johnson WJ, Klass DW. Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int. 3(5), 327-333 (1973).
25. Funck-Brentano JL. Sodium-free water clearance in hemodialysis. Artif. Organs 5(1), 51-53 (1981). (Pubitemid 11096413)
26. Stiller S, Bonnie-Schorn E, Grassmann A et al. A critical review of sodium profiling for hemodialysis. Semin. Dial. 14(5), 337-347 (2001). (Pubitemid 33720874)
27. Locatelli F, Buoncristiani U, Canaud B et al. Haemodialysis with on-line monitoring equipment: tools or toys? Nephrol. Dial. Transplant. 20, 22-33 (2005). (Pubitemid 40207604)
28. Gross M, Maierhofer A, Tetta C, Sénecal L, Canaud B. Online clearance measurement in high-efficiency hemodiafiltration. Kidney Int. 72(12), 1550-1553 (2007). (Pubitemid 350197944)
29. Sperschneider H, Schoeppe R, Schneider S, Stein G. [The impact of different bicarbonate profiles on phosphate elimination in haemodialysis]. Dial. J. 61, 92-98 (1998).
30. Morrison G, Michelson EL, Brown S, Morganroth J. Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int. 17(6), 811-819 (1980). (Pubitemid 10040368)
31. Redaelli B, Locatelli F, Limido D et al. Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. Kidney Int. 50(2), 609-617 (1996). (Pubitemid 26274392)
32. Redaelli B. Electrolyte modelling in haemodialysis - potassium. Nephrol. Dial. Transplant. 11(Suppl. 2), 39-41 (1996). (Pubitemid 26182542)
33. Santoro A, Mancini E, Gaggi R et al. Electrophysiological response to dialysis: the role of dialysate potassium content and profiling. Contrib. Nephrol. 149, 295-305 (1995).
34. Henderson LW. The beginning of clinical hemofiltration: a personal account. ASAIO 49(5), 513-517 (2003). (Pubitemid 37129270)
35. Santoro A, Guarnieri F, Ferramosca E, Grandi F. Acetate-free biofiltration. Contrib. Nephrol. 158, 138-152 (2007).
36. Wratten ML, Ghezzi PM. Hemodiafiltration with endogenous reinfusion. Contrib. Nephrol. 158, 94-102 (2007).
37. Santoro A, Mancini E, Zucchelli P. The impact of hemofiltration on the systemic cardiovascular response. Nephrol. Dial. Transplant. 15(Suppl. 2), 49-54 (2000).
38. Santoro A, Mancini E, Bolzani R et al. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am. J. Kidney Dis. 52(3), 507-518 (2008).
39. Henderson LW, Sanfelippo ML, Beans E. 'On line' preparation of sterile pyrogen-free electrolyte solution. Trans. Am. Soc. Artif. Intern. Organs 24, 465-467 (1978). (Pubitemid 9066151)
40. Ward RA. Ultrapure dialysate: a desirable and achievable goal for routine hemodialysis. Semin. Dial. 13(6), 378-380 (2000).
41. Penne EL, Wisser L, van den Dorpel MA et al. Microbiological quality and quality control of purified water and ultrapure dialysis fluids for on-line hemodiafilttration in routine clinical practice. Kidney Int. 76, 665-672 (2009).
42. Canaud BJ. Changing paradigms of renal replacement therapy in chronic kidney disease patients: ultrapure dialysis fluid and high-efficiency hemodiafiltration for all? Kidney Int. 76(6), 591-593 (2009).
43. Tetta C, David S, Marcelli D et al. Clinical effects of online dialysate and infusion fluids. Hemodial. Int. 10(Suppl. 1), S60-S66 (2006). (Pubitemid 43272412)
44. Lederer SR, Schiffl H. Ultrapure dialysis fluid lowers the cardiovascular morbidity in patients on maintenance hemodialysis by reducing continuous microinflammation. Nephron 91(3), 452-455 (2002). (Pubitemid 34765244)
45. Polaschegg HD. Automatic, noninvasive intradialytic clearance measurment. Int J. Artif. Organs 16(4), 185-191 (1993). (Pubitemid 23208117)
46. Boda D, Gal G, Eck E, Kiss E. Ultraviolettspektrophotometrische untersuchung des serumdialysats von chronisch intermittierend mit der k'nstlichen niere behandelten patienten. Zschr. Urol. 70, 345-349 (1977). (Pubitemid 8099936)
47. Gál G, Gróf J. Continuous UV photometric monitoring of the efficiency of hemodialysis. Int. J. Artif. Organs 6, 338-341 (1980). (Pubitemid 11162657)
48. Depner TA, Keshaviah PR, Ebben JP et al. Multicenter clinical validation of an on-line monitor of dialysis adequacy. J. Am. Soc. Nephrol. 7(3), 464-471 (1996). (Pubitemid 26128317)
49. Eddy CV, Arnold MA. Near-infrared spectroscopy for measuring urea in hemodialysis fluids. Clin. Chem. 47(7), 1279-1286 (2001). (Pubitemid 32579117)
50. Olesberg JT, Arnold MA, Flanigan MJ. Online measurement of urea concentration in spent dialysate during hemodialysis. Clin. Chem. 50(1), 175-181 (2004). (Pubitemid 38125715)
51. Uhlin F, Fridolin I, Lindberg LG, Magnusson M. Estimation of delivered dialysis dose by on-line monitoring of the ultraviolet absorbance in the spent dialysate. Am. J. Kidney Dis. 41(5), 1026-1036 (2003). (Pubitemid 36532137)
52. Scherbakov A, Fridolin I. Dialysis Adequacy On-Line Monitoring Using DiaSens Optical Sensor: Technique and Clinical Application. Katashev A, Dekhtyar Y, Spigulis J (Eds). NBC Proceedings, US Government Print, Washington DC, USA 20, 323-326 (2008).
53. Uhlin F, Fridolin I, Magnusson M, Lindberg LG. Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance. Nephrol. Dial. Transplant. 21(8), 2225-2231 (2006). (Pubitemid 44295049)
54. Uhlin F, Pettersson J, Fernström A, Lindberg LG. Complementary parameter for dialysis monitoring based on UV absorbance. Hemodial. Int. 13(4), 492-497 (2009).
55. Santoro A, Mancini E, Zucchelli P. The impact of haemofiltration on the systemic cardiovascular response. Nephrol. Dial. Transplant. 15(Suppl. 2), 49-54 (2000).
56. Rubinger D, Revis N, Pollak A et al. Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol. Dial. Transplant. 19(8), 2053-2060 (2004). (Pubitemid 39139637)
57. Kamath V, Fallen EL. Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function.' Crit. Rev. Biomed. Eng. 21(3), 245-311 (1993). (Pubitemid 23198884)
58. Bianchi AM, Mainardi LT, Meloni C et al. Continuous monitoring of the sympatho-vagal balance through spectral analysis. IEEE Eng. Med. Biol. Mag. 16 (5), 64-73 (1997). (Pubitemid 27413178)
59. Mackey MC, Milton JG. Dynamical diseases. Ann. NY Acad. Sci. 504, 16-32 (1987).
60. Kleiger RE, Stein PK, Bosner MS, Rottman JN. Time domain measurements of heart rate variability. Cardiol. Clin. 10(3), 487-498 (1992).
61. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 93, 1043-1065 (1996).
62. Lombardi F, Malliani A, Pagani M, Cerutti S. Heart rate variability and its sympatho-vagal modulation. Cardiovasc. Res. 32(2), 208-216 (1996). (Pubitemid 26246864)
63. Barnas MG, Boer WH, Koomans HA. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension, J. Am. Soc. Nephrol. 10(12), 2577-2584 (1999).
64. Pelosi G, Emdin M, Carpeggiani C et al. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability. Clin. Sci. (Lond.) 96(1), 23-31 (1999). (Pubitemid 29045861)
65. Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J. Am. Coll. Cardiol. 27, 270-276 (1996).
66. La Rovere MT, Pinna GD, Maestri R et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107, 565-570 (2003). (Pubitemid 36176805)
67. Lombardi F, Sandrone G, Pernpruner S et al. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. Am. J. Cardiol. 60, 1239-1245 (1987).
68. Chan CT. Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death? Nephrol. Dial. Transplant. 23, 3061-3062 (2008).
69. Sassi R, Cerutti S, Hnatkova K et al. HRV scaling exponent identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone. IEEE Trans. Biomed. Eng. 53, 103-110 (2006). (Pubitemid 43078474)
70. Cerutti S, Esposti F, Ferrario M, Sassi R, Signorini MG. Long-term invariant parameters obtained from 24-h Holter recordings: a comparison between different analysis techniques. Chaos 17(1), 015108 (2007).
71. Peng CK, Havlin S, Stanley HE, Goldberger AL. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos 5, 82-87 (1995).
72. Fukuta H. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol. Dial. Transplant. 18, 318-325 (2003). (Pubitemid 36181683)
73. Cerutti S, Bianchi AM, Reiter H. Analysis of sleep and stress profiles from biomedical signal processing in wearable devices. Conf. Proc. IEEE Eng. Med. Biol. Soc. (Suppl.), 6530-6532 (2006). (Pubitemid 46521419)
74. Mendez MO, Bianchi AM, Matteucci M, Cerutti S, Penzel T. Sleep apnea screening by autoregressive models from a single ECG lead. IEEE Trans. Biomed. Eng. 56(12), 2838-2850 (2009).
75. Gura V, Ronco C, Davenport A. The wearable artificial kidney, why and how: from holy grail to reality. Semin. Dial. 22(1), 13-17 (2009).
76. Cerutti S, Magenes G, Bonato P. Guest editorial special section on smart wearable devices for human health and protection. IEEE Trans. Inf. Technol. Biomed. 14(3), 691-693 (2010)